Evidence map›Paper›PMID 30923130›Full record

ArticleThe Journal of biological chemistry2019

IL-6 exhibits both

Narelle E McGregor, Melissa Murat, Jeevithan Elango, Ingrid J Poulton, Emma C Walker, Blessing Crimeen-Irwin, Patricia W M Ho, Jonathan H Gooi, T John Martin, Natalie A Sims

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed, 2 pooled it
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 2 syntheses or guidelines pooled it, 90 citations in OpenAlex.

  1. The role of CD8Frontiers in immunology · 2026
    Pooled it
  2. Pooled it
  3. S100A9 Induces RANKL Expression in Osteocytes Utilizing IL-6/sIL-6R Combination and gp130 Signaling Pathways.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  4. Article
  5. Review
  6. Interferon-JAK-STAT Axis in Bone Metabolism.Current osteoporosis reports · 2026
    Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Narelle E McGregorFrom the Bone Cell Biology and Disease Unit, St. Vincent's Institute of Medical Research, Melbourne, Victoria 3065, Australia.
Melissa MuratFrom the Bone Cell Biology and Disease Unit, St. Vincent's Institute of Medical Research, Melbourne, Victoria 3065, Australia.
Jeevithan ElangoFrom the Bone Cell Biology and Disease Unit, St. Vincent's Institute of Medical Research, Melbourne, Victoria 3065, Australia.
Ingrid J PoultonFrom the Bone Cell Biology and Disease Unit, St. Vincent's Institute of Medical Research, Melbourne, Victoria 3065, Australia.
Emma C WalkerFrom the Bone Cell Biology and Disease Unit, St. Vincent's Institute of Medical Research, Melbourne, Victoria 3065, Australia.
Blessing Crimeen-IrwinFrom the Bone Cell Biology and Disease Unit, St. Vincent's Institute of Medical Research, Melbourne, Victoria 3065, Australia.
Patricia W M HoFrom the Bone Cell Biology and Disease Unit, St. Vincent's Institute of Medical Research, Melbourne, Victoria 3065, Australia.
Jonathan H Gooithe Department of Medicine, University of Melbourne, St. Vincent's Hospital, Melbourne, Victoria 3065, Australia, and.
T John MartinFrom the Bone Cell Biology and Disease Unit, St. Vincent's Institute of Medical Research, Melbourne, Victoria 3065, Australia.
Natalie A SimsFrom the Bone Cell Biology and Disease Unit, St. Vincent's Institute of Medical Research, Melbourne, Victoria 3065, Australia, nsims@svi.edu.au.ORCID 0000-0003-1421-8468
St Vincents Institute of Medical Research · AUThe University of Melbourne · AULa Trobe University · AUShanghai Ocean University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Interleukin 6 (IL-6) supports development of bone-resorbing osteoclasts by acting early in the osteoblast lineage via membrane-bound (

Indexed as

OsteogenesisSignal TransductionADAM17 ProteinAnimalsCCAAT-Enhancer-Binding Protein-deltaCytokine Receptor gp130Interleukin-6MiceOsteoclastsOsteocytesRANK LigandSuppressor of Cytokine Signaling 3 ProteinADAM17 ProteinAdam17 protein, mouseCCAAT-Enhancer-Binding Protein-deltaCebpd protein, mouseCytokine Receptor gp130Il6st protein, mouseInterleukin-6interleukin-6, mouseRANK LigandSocs3 protein, mouseSuppressor of Cytokine Signaling 3 ProteinTnfsf11 protein, mousebonebone growthcell signalingcytokineinflammationinterleukin 6 (IL-6)osteoblastosteoclastosteocyteosteopeniaSTAT3

Identifiers

PMID30923130
PMCPMC6514630
OpenAlexW2927572451

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.